Know all about the “bivalent” booster jab

The Medicines and Healthcare Products Regulatory Agency (MHRA) says the modified Moderna vaccine against coronavirus, which targets the original version plus a variation of Omicron, meets UK regulatory requirements for safety, quality and efficacy. announced that it was approved after it was determined to meet the

Also read: Hormones that prevent dehydration are associated with increased risk of kidney failure, study claims

After carefully evaluating the data, the Commission on Human Medicines, an independent scientific advisory body to the government, supported the decision to grant approval for this booster vaccination in the UK.

Half of each dose of the booster vaccine “Spikevax bivalent Original/Omicron” will target the 2020 original virus strain and the other half (25 micrograms) will target Omicron.

Based on clinical trial results, the MHRA concluded that booster doses of the bivalent Moderna vaccine produced strong immune responses against both Omicron (BA.1) and the original 2020 strain. In this report, bivalent vaccination was found to be effective in inducing immune responses against the Omicron subvariants BA.4 and BA.5.

None of the adverse effects seen were considered substantial and were consistent with those found at the baseline Modelna Booster dose.

MHRA Chief Executive Dr. June Lane said: distortion. “

“The first-generation COVID-19 vaccine in use in the UK continues to provide important protection against the disease and save lives. As we continue, it’s a tool honed in our arsenal that can help protect us from this disease,” she said.

“We have a comprehensive safety surveillance strategy in place to monitor the safety of all COVID-19 vaccines licensed in the UK, including the vaccine approved today,” she added. rice field.T.

To bring Spikevax Bivalent Original/Omicron to people in the UK, Moderna is working with the Vaccine Task Force, UK Health Security Agency and the National Health Service. Further approval decisions for mRNA-1273.214 are expected from Australia, Canada and the EU, all of which Moderna has applied for approval. Know all about the “bivalent” booster jab

Show More
Back to top button